New hope for teens with schizophrenia: drug trial underway
Disease control
Recruiting now
This study tests a medicine called cariprazine in teenagers aged 13 to 17 with schizophrenia. The goal is to see if it reduces symptoms like delusions and hallucinations over 6 weeks. About 330 teens will take either the drug or a placebo. This is a phase 3 trial, meaning it's on…
Phase: PHASE3 • Sponsor: Gedeon Richter Plc. • Aim: Disease control
Last updated May 26, 2026 12:09 UTC